Patients were randomized in a 1:1 ratio to either once-weekly Wegovy pen 2.4 mg or placebo (with a 16-week dose escalation), both in conjunction with a reduced-calorie diet (~500 kcal/day deficit) and increased physical activity (recommended to a minimum of 150 min/week)
A CytoflexS (Beckman Coulter) flow cytometer was utilized for analysis, and data were analyzed using FlowJo software version 7.6 (Treestar Inc.)
Those extra androgens can also predispose you to weight gain, particularly the accumulation of fat around your middle, for reasons we dont quite understand, Basma Faris, MD, a board-certified ob-gyn at Mount Sinai West, tells SELF
Although the trial did not show a significant advantage in reducing cardiovascular events [6], or hospitalizations, it provided insights into liraglutides safety and tolerability in this patient population [6]